Form 4 for ZION ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0000109380-21-000239 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-12 | 2021-11-10 | ZION | SHIREY TERRY ALAN | EVP, Division CEO | M - OptEx | $49.46 | +8,867 | 22.4K | +65% | +$438.5K |
| D | 2021-11-12 | 2021-11-10 | ZION | SHIREY TERRY ALAN | EVP, Division CEO | S - Sale+OE | $65.71 | -8,867 | 19.8K | -31% | -$582.7K |
| DM | 2021-11-12 | 2021-11-10 | ZION | SHIREY TERRY ALAN | EVP, Division CEO | M - OptEx | $49.46 | -8,867 | 0 | -100% | -$438.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | M | A | 1,613 | $45.65 | 24,049 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-10 | M | A | 2,221 | $51.17 | 26,270 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-10 | M | A | 2,429 | $55.68 | 28,699 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-10 | S | D | 8,867 | $65.71 | 19,832 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $65.632 to $65.776. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2021-11-10 | M | A | 2,604 | $44.55 | 22,436 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2021-11-10 | M | D | 2,429 | $55.68 | 0 | D | $55.68 · — to 2025-02-22 | 2,429 Common Stock | (F2) Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. |
| 7 | Derivative | Stock Option (right to buy) | 2021-11-10 | M | D | 2,221 | $51.17 | 1,111 | D | $51.17 · — to 2026-02-28 | 2,221 Common Stock | (F2) Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. |
| 8 | Derivative | Stock Option (right to buy) | 2021-11-10 | M | D | 1,613 | $45.65 | 3,228 | D | $45.65 · — to 2027-02-09 | 1,613 Common Stock | (F2) Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. |
| 9 | Derivative | Stock Option (right to buy) | 2021-11-10 | M | D | 2,604 | $44.55 | 0 | D | $44.55 · — to 2024-02-23 | 2,604 Common Stock | (F2) Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. |